Siemens' syngo TrueD is designed for oncology, supporting PET/CT, SPECT/CT as well as CT or MR fused with PET or SPECT. The syngo TrueD was de-signed to allow physicians to compare patient scans from different time points (such as pre- and post-therapy) and provide advanced image analysis and comparison.
May 2008
May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...
May 22, 2026 
May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...
May 19, 2026 
April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...
April 29, 2026 
April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...
April 28, 2026 
April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...
April 28, 2026 
April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...
April 23, 2026 
April 20, 2026 — Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in ...
April 23, 2026 
April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...
April 20, 2026 
April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...
April 09, 2026 
The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los ...
April 07, 2026 